Acti-Med GmbH - Freiensteinau

News / Press 

Acti-Med establishes a Group structure

Acti-Med establishes a Group structure, following investment in Europin by Gilde Healthcare

In April we had the pleasure to inform you about the investment of Gilde Healthcare, a specialist private equity investor in Acti-Med. Together with our new shareholders, we continue on our strategic path to form a leading, integrated contract manufacturer for tailor-made cannulas and cannula systems of the highest quality.


Today, we can announce the formation of a joint group together with Europin, following a strategic investment by Gilde Healthcare. Headquartered in Heidelberg (Germany) with a development and production plant in Trenčín (Slovakia), EUROPIN develops and manufactures medical needles, such as pen cannulas and lancet needles for medical and pharmaceutical applications with a focus on injection systems for self-medication in the field of diabetes and hormone therapies. Founded in 1997, EUROPIN has strengthened its market positioning during the last years by evolving its comprehensive product portfolio to become one of the European leaders in its market, with an annual output of more than two billion needles and cannulas.


By joining forces, our group will be able to significantly expand its footprint – in terms of geography as well as breadth and depth of the product portfolio we can offer you as our clients. While forming a joint group, both Europin and Acti-Med will operate separately under one roof while retaining both brands individually in the market. Therefore, there will be no immediate changes for you as a customer of Acti-Med and your contact persons will remain the same.   


We will inform you successively about the progress and extended product and service offering over the course of the next months. The joint group will represent the largest contract manufacturer of raw cannulas and cannula systems in Europe and we look forward an exciting future.